• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于干眼症治疗的载他克莫司阳离子脂质体

Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.

作者信息

Chen Xiang, Wu Jicheng, Lin Xueqi, Wu Xingdi, Yu Xuewen, Wang Ben, Xu Wen

机构信息

Eye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Pharmacol. 2022 Feb 4;13:838168. doi: 10.3389/fphar.2022.838168. eCollection 2022.

DOI:10.3389/fphar.2022.838168
PMID:35185587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8855213/
Abstract

Eye drops are ophthalmic formulations routinely used to treat dry eye. However, the low ocular bioavailability is an obvious drawback of eye drops owing to short ocular retention time and weak permeability of the cornea. Herein, to improve the ocular bioavailability of eye drops, a cationic liposome eye drop was constructed and used to treat dry eye. Tacrolimus liposomes exhibit a diameter of around 300 nm and a surface charge of +30 mV. Cationic liposomes could interact with the anionic ocular surface, extending the ocular retention time and improving tacrolimus amount into the cornea. The cationic liposomes notably prolonged the ocular retention time of eye drops, leading to an increased tacrolimus concentration in the ocular surface. The tacrolimus liposomes were also demonstrated to reduce reactive oxygen species and dry eye-related inflammation factors. The use of drug-loaded cationic liposomes is a good formulation in the treatment of ocular disease; the improved ocular retention time and biocompatibility give tremendous scope for application in the treatment of ocular disease, with further work in the area recommended.

摘要

眼药水是常用于治疗干眼症的眼科制剂。然而,由于眼内滞留时间短和角膜通透性弱,眼药水的低眼生物利用度是一个明显的缺点。在此,为了提高眼药水的眼生物利用度,构建了一种阳离子脂质体眼药水并用于治疗干眼症。他克莫司脂质体的直径约为300纳米,表面电荷为+30毫伏。阳离子脂质体可与阴离子眼表相互作用,延长眼内滞留时间并提高他克莫司进入角膜的量。阳离子脂质体显著延长了眼药水的眼内滞留时间,导致眼表他克莫司浓度增加。他克莫司脂质体还被证明可减少活性氧和干眼症相关炎症因子。载药阳离子脂质体的应用是治疗眼部疾病的良好制剂;改善的眼内滞留时间和生物相容性为眼部疾病的治疗提供了巨大的应用空间,建议在该领域进一步开展工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/6fd18878ce14/fphar-13-838168-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/8023c8def334/fphar-13-838168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/a673daec980b/fphar-13-838168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/67dd0df9c5b2/fphar-13-838168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/6c24199bab93/fphar-13-838168-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/47da7147ffa8/fphar-13-838168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/6fd18878ce14/fphar-13-838168-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/8023c8def334/fphar-13-838168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/a673daec980b/fphar-13-838168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/67dd0df9c5b2/fphar-13-838168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/6c24199bab93/fphar-13-838168-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/47da7147ffa8/fphar-13-838168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e23/8855213/6fd18878ce14/fphar-13-838168-g006.jpg

相似文献

1
Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.用于干眼症治疗的载他克莫司阳离子脂质体
Front Pharmacol. 2022 Feb 4;13:838168. doi: 10.3389/fphar.2022.838168. eCollection 2022.
2
Inhibition of Neovascularization and Inflammation in a Mouse Model of Corneal Alkali Burns Using Cationic Liposomal Tacrolimus.使用阳离子脂质体他克莫司抑制小鼠角膜碱烧伤模型中的新生血管形成和炎症
Front Bioeng Biotechnol. 2021 Dec 7;9:791954. doi: 10.3389/fbioe.2021.791954. eCollection 2021.
3
Mucin-targeting-aptamer functionalized liposomes for delivery of cyclosporin A for dry eye diseases.基于黏蛋白靶向适体的环孢素 A 脂质体用于治疗干眼症。
J Mater Chem B. 2023 May 31;11(21):4684-4694. doi: 10.1039/d3tb00598d.
4
Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.用于他克莫司眼部局部给药的前体脂质体衍生的脂质体:体外角膜渗透、眼部刺激性及体内抗同种异体移植排斥反应
Eur J Pharm Sci. 2014 Oct 1;62:115-23. doi: 10.1016/j.ejps.2014.05.020. Epub 2014 Jun 3.
5
Anti-microbial Effect and in Vivo Ocular Delivery of Ciprofloxacin-loaded Liposome through Rabbit's Eye.载有环丙沙星的脂质体的抗微生物作用及其在兔眼内的眼部递药。
Curr Eye Res. 2020 Oct;45(10):1245-1251. doi: 10.1080/02713683.2020.1728777. Epub 2020 Feb 18.
6
Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus.具有延长滞留时间的阳离子纳米乳作为他克莫司眼部递药有前途的载体。
Eur J Pharm Sci. 2020 Mar 1;144:105229. doi: 10.1016/j.ejps.2020.105229. Epub 2020 Jan 17.
7
Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.用于眼科前药和协同药物设计与递送中视力改善的生物活性抗氧化剂N-乙酰肌肽的眼内药物代谢
Drug Dev Ind Pharm. 2008 Oct;34(10):1071-89. doi: 10.1080/03639040801958413.
8
Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye.将阿奇霉素离子对包封于脂质体中以增强眼部递药并提高干眼症的治疗效果。
Mol Pharm. 2018 Nov 5;15(11):4862-4871. doi: 10.1021/acs.molpharmaceut.8b00516. Epub 2018 Oct 9.
9
[Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].双氯芬酸钠脂质体的制备及其眼部药代动力学
Yao Xue Xue Bao. 2006 Nov;41(11):1094-8.
10
Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.基于硼酸修饰的硫酸软骨素的黏附性纳米结构化脂质载体治疗干眼综合征。
Acta Biomater. 2019 Nov;99:350-362. doi: 10.1016/j.actbio.2019.08.035. Epub 2019 Aug 23.

引用本文的文献

1
Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis.脂质体技术的战略进展:用于皮肤疾病透皮给药的转化范例
J Nanobiotechnology. 2025 Aug 21;23(1):576. doi: 10.1186/s12951-025-03660-z.
2
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.用于罕见眼科疾病的纳米囊泡给药系统:进展、挑战与未来方向
AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8.
3
Double Peptide-Functionalized Carboxymethyl Chitosan-Coated Liposomes Loaded with Dexamethasone as a Potential Strategy for Active Targeting Drug Delivery.

本文引用的文献

1
Ferrostatin-1-loaded liposome for treatment of corneal alkali burn via targeting ferroptosis.载有铁死亡抑制因子-1的脂质体通过靶向铁死亡治疗角膜碱烧伤。
Bioeng Transl Med. 2021 Dec 8;7(2):e10276. doi: 10.1002/btm2.10276. eCollection 2022 May.
2
Preparation of Liposomal Formulations for Ocular Delivery of Thymoquinone: In Vitro Evaluation in HCEC-2 e HConEC Cells.用于眼用递送百里醌的脂质体制剂的制备:在HCEC-2和HConEC细胞中的体外评价
Pharmaceutics. 2021 Dec 5;13(12):2093. doi: 10.3390/pharmaceutics13122093.
3
Effectiveness of an ocular adhesive polyhedral oligomeric silsesquioxane hybrid thermo-responsive FK506 hydrogel in a murine model of dry eye.
负载地塞米松的双肽功能化羧甲基壳聚糖包被脂质体作为主动靶向给药的潜在策略
Int J Mol Sci. 2025 Jan 22;26(3):922. doi: 10.3390/ijms26030922.
4
Layer-by-Layer Biopolymer-Coated Deformable Liposomes-In Situ Gel: A Hybrid Strategy for Enhanced Ocular Delivery of Itraconazole: In Vitro and In Vivo Appraisal.逐层生物聚合物包被的可变形脂质体原位凝胶:一种增强伊曲康唑眼部给药的混合策略:体外和体内评价
Gels. 2024 Dec 31;11(1):19. doi: 10.3390/gels11010019.
5
Biomimetic Curcumin-Loaded Liposomes for the Treatment of Dry Eyes and Meibomian Gland Dysfunction: An In Vivo Study.用于治疗干眼症和睑板腺功能障碍的仿生载姜黄素脂质体:一项体内研究
J Clin Med. 2024 Oct 27;13(21):6436. doi: 10.3390/jcm13216436.
6
Scanning Electron Microscopy (SEM) Evaluation of the Ultrastructural Effects on Conjunctival Epithelial Cells of a New Multiple-Action Artificial Tear Containing Cross-Linked Hyaluronic Acid, Cationic Liposomes and Trehalose.扫描电子显微镜(SEM)评估一种新型多效人工泪液对结膜上皮细胞超微结构的影响,该人工泪液含有交联透明质酸、阳离子脂质体和海藻糖。
Biomedicines. 2024 Aug 23;12(9):1945. doi: 10.3390/biomedicines12091945.
7
A novel liposomal formulation for ocular delivery of caspofungin: an experimental study by quality by design-based approach.一种新型卡泊芬净眼用脂质体制剂:基于质量源于设计的实验研究。
Ther Deliv. 2024;15(9):667-683. doi: 10.1080/20415990.2024.2379756. Epub 2024 Aug 5.
8
Oleogels for the ocular delivery of epalrestat: formulation, in vitro, in ovo, ex vivo and in vivo evaluation.用于依帕司他眼部递药的油凝胶:制剂、体外、鸡胚、离体和体内评价。
Drug Deliv Transl Res. 2024 Nov;14(11):3291-3308. doi: 10.1007/s13346-024-01560-7. Epub 2024 May 23.
9
Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease.用于治疗干眼症的纳米技术的最新进展
Nanomaterials (Basel). 2024 Apr 12;14(8):669. doi: 10.3390/nano14080669.
10
Langmuir monolayer studies of non-ionic surfactants and DOTMA for the design of ophthalmic niosomes.用于眼科脂质体设计的非离子表面活性剂和DOTMA的朗缪尔单分子层研究
Heliyon. 2024 Feb 10;10(4):e25887. doi: 10.1016/j.heliyon.2024.e25887. eCollection 2024 Feb 29.
眼部黏附性多面体低聚倍半硅氧烷杂化热响应性FK506水凝胶在小鼠干眼模型中的有效性
Bioact Mater. 2021 Jul 28;9:77-91. doi: 10.1016/j.bioactmat.2021.07.027. eCollection 2022 Mar.
4
Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization.载有眼部Wnt/β-连环蛋白通路抑制剂XAV939的脂质体用于治疗碱烧伤角膜伤口和新生血管形成
Front Bioeng Biotechnol. 2021 Oct 26;9:753879. doi: 10.3389/fbioe.2021.753879. eCollection 2021.
5
Autoimmunity in dry eye disease - An updated review of evidence on effector and memory Th17 cells in disease pathogenicity.干燥性眼疾中的自身免疫 - 对效应器和记忆性 Th17 细胞在疾病发病机制中作用的证据的最新综述。
Autoimmun Rev. 2021 Nov;20(11):102933. doi: 10.1016/j.autrev.2021.102933. Epub 2021 Sep 9.
6
Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease.用于治疗干眼症的载地塞米松纳米结构脂质载体
Pharmaceutics. 2021 Jun 18;13(6):905. doi: 10.3390/pharmaceutics13060905.
7
Ocular drug delivery to the anterior segment using nanocarriers: A mucoadhesive/mucopenetrative perspective.利用纳米载体实现前节段眼部药物传递:黏膜黏附/黏膜渗透视角。
J Control Release. 2021 Aug 10;336:71-88. doi: 10.1016/j.jconrel.2021.06.011. Epub 2021 Jun 10.
8
Analysis of aqueous humor total antioxidant capacity and its correlation with corneal endothelial health.房水总抗氧化能力分析及其与角膜内皮健康的相关性。
Bioeng Transl Med. 2020 Dec 5;6(2):e10199. doi: 10.1002/btm2.10199. eCollection 2021 May.
9
Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.利用纳米氧化铈的可调谐腔增强Y-27632介导的眼内高压缓解作用。
Theranostics. 2021 Mar 13;11(11):5447-5463. doi: 10.7150/thno.54525. eCollection 2021.
10
Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer.吉西他滨和阿霉素负载于免疫刺激型单磷酰脂质A脂质体中用于治疗乳腺癌。
Bioeng Transl Med. 2020 Sep 16;6(1):e10188. doi: 10.1002/btm2.10188. eCollection 2021 Jan.